ORG Wealth Partners’s Biogen BIIB Stock Holding History

ORG Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.4K	Hold	349	–	–	0.01%	313
2026 Q1	$64K	Hold	349	–	–	0.01%	314
2025 Q4	$61.4K	Hold	349	–	–	0.01%	307
2025 Q3	$48.9K	Buy	+349	New	+$47.2K	0.01%	325

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ORG Wealth Partners's BIIB Position: Q2 2026 in Review

ORG Wealth Partners held its Biogen (BIIB) position steady in Q2 2026 at 349 shares worth $75.4K. The position accounts for 0.01% of the portfolio, ranked #313.

ORG Wealth Partners first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

ORG Wealth Partners held 349 shares of Biogen worth $75.4K as of Q2 2026.
ORG Wealth Partners left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #313 holding.
ORG Wealth Partners first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.